交银国际(03329.HK)两附属共斥1,500万人币注资合夥企业
交银国际(03329.HK)公布,间接全资附属上海博乐作为普通合夥人,与间接非全资附属交银科创股权投资基金、中水汇金、于氏、刘氏、胡氏及李氏(作为有限合夥人)就成立合夥企业订立合夥企业协议。所有合夥人向合夥企业的注资总额将为2,015万元人民币(下同),其中上海博乐及交银科创股权投资基金各自将分别注资100万元及1,400万元。交易仍有待中国相关政府机构批准。
合夥企业嘉兴恒升股权投资基金合夥企业,旨在进行项目投资业务以主要透过收购、持有及出售目标公司股权。
公司控股股东交通银行透过其附属交银国信持有交银科创股权投资基金10%以上的合夥企业权益,交银科创股权投资基金为公司之关连附属。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.